Drug Landscape ›
vitamin A and E ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 11
Most-reported reactions
Infection — 2 reports (18.18%) Application Site Pain — 1 report (9.09%) Back Pain — 1 report (9.09%) Bone Pain — 1 report (9.09%) Cataract — 1 report (9.09%) Chronic Sinusitis — 1 report (9.09%) Constipation — 1 report (9.09%) Dizziness — 1 report (9.09%) Dyskinesia — 1 report (9.09%) Ear Pain — 1 report (9.09%)
Source database →
vitamin A and E in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is vitamin A and E approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for vitamin A and E in United States?
Cairo University is the originator. The local marketing authorisation holder may differ — check the official source linked above.